Literature DB >> 35505037

In Vitro Potentiation of Antimicrobial Photodynamic Inactivation by Addition of Potassium Iodide.

Nasim Kashef1, Michael R Hamblin2.   

Abstract

The current increase in antibiotic resistance worldwide and the emergence of microbial strains that are resistant to all known antibiotics have stimulated research into novel strategies such as aPDI that are thought to be unlikely to lead to the development of resistance. Although many studies have reported in vitro aPDI killing of microorganisms by a range of different photosensitizers, there are still limitations to the effectiveness of aPDI, and recurrence of bacterial growth may occur in animal studies after completion of the illumination. In this chapter we cover a novel and relatively simple method to improve the efficacy of aPDI against Gram-positive Staphylococcus aureus, Gram-negative Escherichia coli, and fungal yeast Candida albicans by the addition of potassium iodide, a nontoxic inorganic salt. Under some circumstances up to six-logs additional killing can be obtained.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antimicrobial photodynamic inactivation; Gram-negative bacteria; Gram-positive bacteria; Potassium iodide; Potentiation; Sodium azide; Sodium bromide

Mesh:

Substances:

Year:  2022        PMID: 35505037     DOI: 10.1007/978-1-0716-2099-1_32

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  29 in total

1.  Photodynamic therapy: a new antimicrobial approach to infectious disease?

Authors:  Michael R Hamblin; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2004-02-12       Impact factor: 3.982

Review 2.  Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments.

Authors:  Martin J Garland; Corona M Cassidy; David Woolfson; Ryan F Donnelly
Journal:  Future Med Chem       Date:  2009-07       Impact factor: 3.808

Review 3.  Photophysical and photobiological processes in the photodynamic therapy of tumours.

Authors:  M Ochsner
Journal:  J Photochem Photobiol B       Date:  1997-05       Impact factor: 6.252

4.  Type I and Type II mechanisms of antimicrobial photodynamic therapy: an in vitro study on gram-negative and gram-positive bacteria.

Authors:  Liyi Huang; Yi Xuan; Yuichiro Koide; Timur Zhiyentayev; Masamitsu Tanaka; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2012-07-03       Impact factor: 4.025

5.  Photodynamic Therapy for Cancer and for Infections: What Is the Difference?

Authors:  Sulbha K Sharma; Pawel Mroz; Tianhong Dai; Ying-Ying Huang; Tyler G St Denis; Michael R Hamblin
Journal:  Isr J Chem       Date:  2012-09       Impact factor: 3.333

Review 6.  Photodynamic therapy for localized infections--state of the art.

Authors:  Tianhong Dai; Ying-Ying Huang; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2009 Sep-Dec       Impact factor: 3.631

Review 7.  Antimicrobial photodynamic inactivation: a bright new technique to kill resistant microbes.

Authors:  Michael R Hamblin
Journal:  Curr Opin Microbiol       Date:  2016-07-13       Impact factor: 7.934

Review 8.  Use of fluorescent probes for ROS to tease apart Type I and Type II photochemical pathways in photodynamic therapy.

Authors:  Maria Garcia-Diaz; Ying-Ying Huang; Michael R Hamblin
Journal:  Methods       Date:  2016-07-01       Impact factor: 3.608

Review 9.  New and alternative approaches to tackling antibiotic resistance.

Authors:  Glenn S Tillotson; Nicolette Theriault
Journal:  F1000Prime Rep       Date:  2013-12-03

Review 10.  Strategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptides.

Authors:  Letícia S Tavares; Carolina S F Silva; Vinicius C de Souza; Vânia L da Silva; Cláudio G Diniz; Marcelo O Santos
Journal:  Front Microbiol       Date:  2013-12-31       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.